Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of Prostate Cancer

NCT07163910 is registered in ClinicalTrials.gov with baotai Liang as lead sponsor.

NCT NCT07163910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07163910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of Prostate Cancer
Lead sponsor
baotai Liang
Phase
Phase 2
Overall status
Recruiting
Start date
April 20, 2025
Completion date
December 20, 2027
Enrollment
93 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer